[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345381-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345381-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","decoding-the-oncogenic-role-of-usp22-through-pan-cancer-genomic-and-epigenetic-analysis-original-article","Decoding the Oncogenic Role of USP22 Through Pan-Cancer Genomic and Epigenetic Analysis - Original Article","","Ubiquitin-specific protease 22 (USP22) is a catalytic component of the human SAGA complex that regulates histone deubiquitination and methylation, thereby shaping gene expression, cancer progression, and therapy resistance. A pan-cancer analysis across 33 TCGA cancer types evaluates USP22 expression, genetic alterations, survival outcomes, immune associations, DNA methylation patterns, and protein interactions. USP22 is elevated in multiple cancers and correlates with poorer survival. Lower CpG methylation aligns with tumor-associated upregulation, suggesting therapeutic relevance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/decoding-the-oncogenic-role-of-usp22-through-pan-cancer-genomic-and-epigenetic-analysis-original-article/345381/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/decoding-the-oncogenic-role-of-usp22-through-pan-cancer-genomic-and-epigenetic-analysis-original-article/345381.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the biological role of USP22 in cancer biology?","Question",{"text":63,"@type":64},"USP22 regulates deubiquitination and methylation of histones within the human SAGA complex, influencing gene expression. Its overexpression is associated with altered regulation, cancer progression, and therapy resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was USP22 analyzed across cancers in this study?",{"text":68,"@type":64},"USP22 expression was examined using Human Protein Atlas, UALCAN, and TIMER 2.0 across 33 TCGA cancer types. The analysis also includes genetic changes, overall survival (OS), disease-free survival (DFS), DNA methylation profiles, immune associations, and protein–protein interactions.",{"name":70,"@type":61,"acceptedAnswer":71},"What clinical significance did elevated USP22 expression show?",{"text":72,"@type":64},"USP22 expression was higher in multiple cancer types, with associations to worse survival outcomes and a lower OS rate in several cancers. The study links high USP22 to an immunosuppressive microenvironment and hypomethylation in tumor samples.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345381,1791485159,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nDecoding the Oncogenic Role of USP22 Through Pan-Cancer Genomic and Epigenetic Analysis  \nUma Devi A. | Prakash Kumar Shukla   \nCenter for Bioseparation Technology, VIT, Vellore, India  \nCorrespondence: Prakash Kumar Shukla ([prakash.shukla@vit.ac.in](prakash.shukla@vit.ac.in))  \nReceived: 15 September 2025 | Revised: 25 April 2026 | Accepted: 29 April 2026  \nABSTRACT  \nBackground: Ubiquitin-specific protease 22, an important catalytic component of the human SAGA (Spt-Ada-GcN5 Acetyltransferase) complex, regulates the deubiquitination and methylation of histones, which in turn influences gene expression. Its overexpression alters gene regulation, transcription, cancer progression, and therapy resistance. Its role is increasingly being noticed in cancers.  \nAims: To conducted a pan-cancer analysis across multiple malignancies, as it allows for a comprehensive assessment of USP22 expression, regulation, and clinical impact.  \nMethods: The Human Protein Atlas, UALCAN, and Timer 2.0 were used to examine USP22 expression at the gene and protein levels in 33 TCGA cancer types. Furthermore, various tools have been employed to study genetic changes, overall survival (OS), disease-free survival (DFS), DNA methylation profiles, and immune associations. Gene correlation and protein–protein interaction were examined.  \nResults: USP22 expression level was observed to be significantly higher in 13 distinct cancer types among the 33 TCGA cancer types. Along with the pathological stages of the TCGA sample, it showed overexpression in the histological subtypes, TP53 mutant stages, and tumor grade in numerous cancers compared to the control. According to the study, elevated USP22 expression was linked to a worse chance of survival and a lower OS rate in several types of cancer. High expression of USP22 is linked to a poor immunosuppressive microenvironment, and the CpG-aggregated methylation analysis shows that the gene is significantly hypomethylated in tumor samples, which is highly associated with its known upregulation in cancer.  \nConclusion: USP22 may have potential relevance in cancer, and the pathways associated with it could offer possible targets for therapeutic intervention.  \n1 | Introduction  \nThe posttranslational modification influences the functions and destination of most proteins. Ubiquitination is one of the modifications that involves the addition of a small protein ubiquitin, which consists of 76 amino acids, to the substrate lysine [1] . Three enzymes function sequentially to ubiquitinate target substrates: (1) a ubiquitin (Ub)-activating enzyme (E1) charges ubiquitin,(2) an Ub-conjugating enzyme (E2) transfers ubiquitin to substrate lysine with the help of (3) an Ub ligase (E3) [2] . The substrate/target protein ubiquitination status is maintained in equilibrium by deubiquitinases (DUBs), which hydrolyze  \nubiquitinated substrate at isopeptide bonds [3] . The human genome encodes about 100 DUBs [4] and is divided into eight subfamilies according to the structure of their catalytic domain. The most widely distributed DUB subfamily is made up of USPs, which include 58 vertebrate members [5] . DUBs control cellular differentiation, cell cycle regulation, endocytosis, membrane receptor signaling, DNA-dependent activities, protein quality control, and cell survival and death, regulating numerous physiological functions [5, 6] .  \nThe chromatin that houses the cellular genome needs to be remodeled during transcription, DNA replication, and cell  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s). Cancer Reports published by Wiley Periodicals LLC.  \nCancer Reports, 2026; 9:e70572 1 of 19  \n[https://doi.org/10.1002/cnr2.70572](https://doi.org/10.1002/cnr2.70572)  \ndivision. Several posttranslational modificat","cbCaiioORmpobu5F","https://ap.wps.com/l/cbCaiioORmpobu5F","pdf",7237150,"English","# ABSTRACT\n## Background\n## Aims\n## Methods\n## Results\n## Conclusion\n# 1 | Introduction","[{\"question\":\"What is the biological role of USP22 in cancer biology?\",\"answer\":\"USP22 regulates deubiquitination and methylation of histones within the human SAGA complex, influencing gene expression. Its overexpression is associated with altered regulation, cancer progression, and therapy resistance.\"},{\"question\":\"How was USP22 analyzed across cancers in this study?\",\"answer\":\"USP22 expression was examined using Human Protein Atlas, UALCAN, and TIMER 2.0 across 33 TCGA cancer types. The analysis also includes genetic changes, overall survival (OS), disease-free survival (DFS), DNA methylation profiles, immune associations, and protein–protein interactions.\"},{\"question\":\"What clinical significance did elevated USP22 expression show?\",\"answer\":\"USP22 expression was higher in multiple cancer types, with associations to worse survival outcomes and a lower OS rate in several cancers. The study links high USP22 to an immunosuppressive microenvironment and hypomethylation in tumor samples.\"}]","Decoding the Oncogenic Role of USP22 Through Pan-Cancer Genomic and Epigenetic Analysis - Original Article | PDF",1790057487,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6e89e8cce1300e1132d79d9a6eaf85a.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb328e83d2f149d979605bffd0d0d344.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0fa817eea1aaf713a0f34c8696392b0.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdeba0dbbdb0075b1c334355328f756d.webp",980,1287]